Golgin A5 pseudogene

Golgin A5 pseudogene (ENSG00000258665) is a genomic DNA sequence similar to the protein-coding golgin A5 gene but is classified as a pseudogene due to predicted loss of protein-coding capacity from mutations such as frameshifts or premature stop codons[1][3][5]. Pseudogenes generally do not encode functional proteins, though some may produce regulatory non-coding RNAs; for golgin A5 pseudogene, there is no evidence of such function. Pseudogenes as a group have been implicated in cancer biology through differential expression in tumors, but specific data for golgin A5 pseudogene is absent[2][3]. The locus is not recognized as a conventional drug target, receptor, or biomarker, and there are no known interacting drugs or therapeutic mechanisms involving it[4]. The presence of this pseudogene may simply reflect evolutionary genome dynamics and gene duplication events, not an active role in physiological or pathological processes for this specific pseudogene[1][3].